Compare HIVE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIVE | EVMN |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.2M | 717.5M |
| IPO Year | 2017 | N/A |
| Metric | HIVE | EVMN |
|---|---|---|
| Price | $3.95 | $20.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $6.44 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 36.1M | 408.0K |
| Earning Date | 02-17-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,791,000.00 | N/A |
| Revenue This Year | $169.51 | N/A |
| Revenue Next Year | $39.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 158.32 | N/A |
| 52 Week Low | $1.60 | $13.89 |
| 52 Week High | $7.84 | $33.20 |
| Indicator | HIVE | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 42.16 |
| Support Level | $2.64 | $18.64 |
| Resistance Level | $4.33 | $21.21 |
| Average True Range (ATR) | 0.44 | 1.39 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 34.69 | 24.34 |
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.